Whether pembrolizumab given both before surgery (neoadjuvant therapy) and after surgery (adjuvant therapy), as compared with pembrolizumab given as adjuvant therapy alone, would increase event-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback